These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18395180)

  • 1. [New anti-Gram+antibiotics: which role in infective endocarditis?].
    Makinson A; Le Moing V
    Ann Cardiol Angeiol (Paris); 2008 Apr; 57(2):88-92. PubMed ID: 18395180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linezolid- and vancomycin-resistant Enterococcus faecium endocarditis: successful treatment with tigecycline and daptomycin.
    Jenkins I
    J Hosp Med; 2007 Sep; 2(5):343-4. PubMed ID: 17935250
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic perspectives of linezolid in the management of infections due to multiresistant Gram-positive pathogens].
    Manfredi R
    Recenti Prog Med; 2007 Mar; 98(3):143-54. PubMed ID: 17484159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New antibiotics for the treatment of severe staphylococcal infection in the critically ill patient.
    Schmidt-Ioanas M; de Roux A; Lode H
    Curr Opin Crit Care; 2005 Oct; 11(5):481-6. PubMed ID: 16175036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with recently approved antibiotics.
    Paterson DL
    Curr Opin Pharmacol; 2006 Oct; 6(5):486-90. PubMed ID: 16904377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of infections caused by resistant Staphylococcus aureus.
    Anstead GM; Quinones-Nazario G; Lewis JS
    Methods Mol Biol; 2007; 391():227-58. PubMed ID: 18025681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment options for vancomycin-resistant enterococcal infections.
    Linden PK
    Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and new antimicrobial agents.
    Eliopoulos GM
    Am Heart J; 2004 Apr; 147(4):587-92. PubMed ID: 15077072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Staphylococcus aureus and antibiotic resistance].
    Sancak B
    Mikrobiyol Bul; 2011 Jul; 45(3):565-76. PubMed ID: 21935792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the treatment of infections due to resistant Staphylococcus aureus.
    Anstead GM; Owens AD
    Curr Opin Infect Dis; 2004 Dec; 17(6):549-55. PubMed ID: 15640709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotics for gram-positive bacterial infections. Vancomycin, teicoplanin, quinupristin/dalfopristin, and linezolid.
    Lundstrom TS; Sobel JD
    Infect Dis Clin North Am; 2000 Jun; 14(2):463-74. PubMed ID: 10829266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: emerging problems and new prospects for management.
    Noskin GA
    Ann Acad Med Singap; 2001 May; 30(3):320-31. PubMed ID: 11455748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinupristin-dalfopristin and linezolid: evidence and opinion.
    Eliopoulos GM
    Clin Infect Dis; 2003 Feb; 36(4):473-81. PubMed ID: 12567306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinupristin-dalfopristin versus linezolid for the treatment of vancomycin-resistant Enterococcus faecium bacteraemia: efficacy and development of resistance.
    Chong YP; Lee SO; Song EH; Lee EJ; Jang EY; Kim SH; Choi SH; Kim MN; Jeong JY; Woo JH; Kim YS
    Scand J Infect Dis; 2010 Jul; 42(6-7):491-9. PubMed ID: 20524781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New antimicrobial agents for the treatment of Gram-positive bacterial infections.
    Aksoy DY; Unal S
    Clin Microbiol Infect; 2008 May; 14(5):411-20. PubMed ID: 18261129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotics for gram-positive bacterial infections: vancomycin, quinupristin-dalfopristin, linezolid, and daptomycin.
    Lundstrom TS; Sobel JD
    Infect Dis Clin North Am; 2004 Sep; 18(3):651-68, x. PubMed ID: 15308280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotics for gram-positive bacterial infections: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, dalbavancin, and telavancin.
    Nailor MD; Sobel JD
    Infect Dis Clin North Am; 2009 Dec; 23(4):965-82, ix. PubMed ID: 19909893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two new treatment options for infections due to drug-resistant gram-positive cocci.
    Rehm SJ
    Cleve Clin J Med; 2002 May; 69(5):397-401, 405-13. PubMed ID: 12022383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftobiprole is superior to vancomycin, daptomycin, and linezolid for treatment of experimental endocarditis in rabbits caused by methicillin-resistant Staphylococcus aureus.
    Tattevin P; Basuino L; Bauer D; Diep BA; Chambers HF
    Antimicrob Agents Chemother; 2010 Feb; 54(2):610-3. PubMed ID: 19917746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel antibacterial agents for skin and skin structure infections.
    Schweiger ES; Weinberg JM
    J Am Acad Dermatol; 2004 Mar; 50(3):331-40; quiz 341-2. PubMed ID: 14988672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.